$1.31
-0.04-2.96%
Pre-Market: 7:14 PM EDT
15 minutes delayed
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Akebia Therapeutics in recent months.
Browse guidance and forecast on all stocks.